Statistical Comparison of Dissolution Profiles to Predict the Bioequivalence of Extended Release Formulations

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 4

Abstract

The online version of this article (doi:10.1208/s12248-014-9615-6) contains supplementary material, which is available to authorized users.

Authors and Affiliations

J. D. Gomez-Mantilla, U. F. Schaefer, V. G. Casabo, T. Lehr, C. M. Lehr

Keywords

Related Articles

Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters

The plasma membrane monoamine transporters terminate neurotransmission by removing dopamine, norepinephrine, or serotonin from the synaptic cleft between neurons. Specific inhibitors for these transporters, including the...

Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist

Macitentan is a dual endothelin receptor antagonist under phase 3 investigation in pulmonary arterial hypertension. We investigated the effect of cyclosporine (Cs) and rifampin on the pharmacokinetics of macitentan and i...

First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry

Since the federal authorities scheduled the first synthetic cannabinoids, JWH-018 and JWH-073, new synthetic cannabinoids were robustly marketed. N-(1-Adamantyl)-1-pentylindazole-3-carboxamide (AKB-48), also known as API...

Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication

We evaluated a new approach to AIDS therapy by using combinations of oligodeoxynucleotides (ODNs), delivered with a lipid-based carrier system, that target different HIV viral genome sites. We identified some of the fact...

In vitro–In Vivo Correlations: Tricks and Traps

In vitro–in vivo correlation (IVIVC) is a biopharmaceutical tool recommended to be used in development of formulation. When validated, it can speed up development of formulation, be used to fix dissolution limits...

Download PDF file
  • EP ID EP681704
  • DOI  10.1208/s12248-014-9615-6
  • Views 111
  • Downloads 0

How To Cite

J. D. Gomez-Mantilla, U. F. Schaefer, V. G. Casabo, T. Lehr, C. M. Lehr (2014). Statistical Comparison of Dissolution Profiles to Predict the Bioequivalence of Extended Release Formulations. The AAPS Journal, 16(4), -. https://europub.co.uk/articles/-A-681704